These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 11754690)

  • 21. Anakinra (interleukin-1 receptor antagonist) has positive effects on function and quality of life in patients with rheumatoid arthritis.
    Kavanaugh A
    Adv Ther; 2006; 23(2):208-17. PubMed ID: 16751154
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Current management: Management of rheumatic diseases in the era of biological anti-rheumatic drugs.
    Konttinen YT; Seitsalo S; Lehto M; Santavirta S
    Acta Orthop; 2005 Oct; 76(5):614-9. PubMed ID: 16263606
    [No Abstract]   [Full Text] [Related]  

  • 23. Anakinra: a review of its use in the management of rheumatoid arthritis.
    Waugh J; Perry CM
    BioDrugs; 2005; 19(3):189-202. PubMed ID: 15984903
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The safety of interleukin-1 receptor antagonist (anakinra) in the treatment of rheumatoid arthritis].
    Riente L
    Reumatismo; 2004; 56(1 Suppl 1):74-9. PubMed ID: 15201943
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Concomitant medication use in a large, international, multicenter, placebo controlled trial of anakinra, a recombinant interleukin 1 receptor antagonist, in patients with rheumatoid arthritis.
    Tesser J; Fleischmann R; Dore R; Bennett R; Solinger A; Joh T; Modafferi D; Schechtman J;
    J Rheumatol; 2004 Apr; 31(4):649-54. PubMed ID: 15088288
    [TBL] [Abstract][Full Text] [Related]  

  • 26. FDA approves first biologic treatment for sepsis.
    FDA Consum; 2002; 36(1):3. PubMed ID: 11881595
    [No Abstract]   [Full Text] [Related]  

  • 27. A multicentre, double blind, randomised, placebo controlled trial of anakinra (Kineret), a recombinant interleukin 1 receptor antagonist, in patients with rheumatoid arthritis treated with background methotrexate.
    Cohen SB; Moreland LW; Cush JJ; Greenwald MW; Block S; Shergy WJ; Hanrahan PS; Kraishi MM; Patel A; Sun G; Bear MB;
    Ann Rheum Dis; 2004 Sep; 63(9):1062-8. PubMed ID: 15082469
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The 'alphabet' of rheumatoid arthritis treatment.
    Capriotti T
    Medsurg Nurs; 2004 Dec; 13(6):420-8. PubMed ID: 15714747
    [No Abstract]   [Full Text] [Related]  

  • 29. [Treatment of chronic polyarthritis with a human recombinant interleukin 1 receptor antagonist].
    Rau R; Sander O; Musikic P
    Z Rheumatol; 1998 Oct; 57(5):312-9. PubMed ID: 9864837
    [No Abstract]   [Full Text] [Related]  

  • 30. A multicenter, double-blind, dose-ranging, randomized, placebo-controlled study of recombinant human interleukin-1 receptor antagonist in patients with rheumatoid arthritis: radiologic progression and correlation of Genant and Larsen scores.
    Jiang Y; Genant HK; Watt I; Cobby M; Bresnihan B; Aitchison R; McCabe D
    Arthritis Rheum; 2000 May; 43(5):1001-9. PubMed ID: 10817552
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Potential therapeutic uses of interleukin 1 receptor antagonists in human diseases.
    Hallegua DS; Weisman MH
    Ann Rheum Dis; 2002 Nov; 61(11):960-7. PubMed ID: 12379516
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anakinra: an inhibitor of IL-1 for the treatment of rheumatoid arthritis.
    Fleischmann R; Stern R; Iqbal I
    Expert Opin Biol Ther; 2004 Aug; 4(8):1333-44. PubMed ID: 15268666
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anakinra (Kineret) for rheumatoid arthritis.
    Med Lett Drugs Ther; 2002 Feb; 44(1124):18-9. PubMed ID: 11856953
    [No Abstract]   [Full Text] [Related]  

  • 34. Kineret. Easing the pain of rheumatoid arthritis.
    Nursing; 2002 Apr; 32(4):26. PubMed ID: 11969009
    [No Abstract]   [Full Text] [Related]  

  • 35. The use of anakinra, an interleukin-1 receptor antagonist, in the treatment of rheumatoid arthritis.
    Cohen SB
    Rheum Dis Clin North Am; 2004 May; 30(2):365-80, vii. PubMed ID: 15172046
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Anakinra in the treatment of rheumatoid arthritis].
    Loft AG; Tarp U; Thomsen BS
    Ugeskr Laeger; 2003 Sep; 165(39):3720-4. PubMed ID: 14558384
    [No Abstract]   [Full Text] [Related]  

  • 37. Anakinra: review of recombinant human interleukin-I receptor antagonist in the treatment of rheumatoid arthritis.
    Furst DE
    Clin Ther; 2004 Dec; 26(12):1960-75. PubMed ID: 15823761
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Drotrecogin alfa: too early to give it early.
    Smith B
    Emerg Med Australas; 2005 Apr; 17(2):179-80. PubMed ID: 15796737
    [No Abstract]   [Full Text] [Related]  

  • 39. [Recommendations of the Deutschen Gesellschaft für Rheumatologie on therapy of rheumatoid arthritis with the interleukin-1-receptor-antagonist Akakinra (KINERET)].
    Manger B;
    Z Rheumatol; 2002 Dec; 61(6):698-700. PubMed ID: 12491134
    [No Abstract]   [Full Text] [Related]  

  • 40. Observational study on efficacy, safety, and drug survival of anakinra in rheumatoid arthritis patients in clinical practice.
    den Broeder AA; de Jong E; Franssen MJ; Jeurissen ME; Flendrie M; van den Hoogen FH
    Ann Rheum Dis; 2006 Jun; 65(6):760-2. PubMed ID: 16269431
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.